Quality analysis of in vivo near-infrared fluorescence and conventional gamma images acquired using a dual-labeled tumor-targeting probe

Journal of Biomedical Optics

Volumn 10, Issue 5, 2005, Pages

  Houston, Jessica P ^a,c   Ke, Shi ^b,c   Wang, Wei ^b   Li, Chun ^b   Sevick Muraca, Eva M ^a,c  

^a TEXAS A AND M UNIVERSITY   (United States)

^b UNIVERSITY OF TEXAS   (United States)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Continuous wave; Contrast agent; Fluorescence enhanced optical imaging; Molecular imaging of cancer; Photon migration

Indexed keywords

CYCLOPEPTIDE; DIAGNOSTIC AGENT; INDIUM; INDOLE DERIVATIVE; IRDYE800; RADIOPHARMACEUTICAL AGENT;

ANIMAL; ARTICLE; COMPARATIVE STUDY; DRUG DELIVERY SYSTEM; EVALUATION; FLUORESCENCE MICROSCOPY; GENETIC PROCEDURES; HUMAN; INFRARED SPECTROPHOTOMETRY; MALE; MELANOMA; METHODOLOGY; MOUSE; NUDE MOUSE; PATHOLOGY; REPRODUCIBILITY; SCINTISCANNING; SENSITIVITY AND SPECIFICITY; STAINING;

ANIMALS; DRUG DELIVERY SYSTEMS; HUMANS; INDIUM RADIOISOTOPES; INDOLES; MALE; MELANOMA; MICE; MICE, NUDE; MICROSCOPY, FLUORESCENCE; MOLECULAR PROBE TECHNIQUES; PEPTIDES, CYCLIC; RADIONUCLIDE IMAGING; RADIOPHARMACEUTICALS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SPECTROPHOTOMETRY, INFRARED; STAINING AND LABELING;

CHARGE COUPLED DEVICES; DYES; FLUORESCENCE; IMAGING TECHNIQUES; PHOTONS; PROBES; SIGNAL TO NOISE RATIO; TOMOGRAPHY;

CONTINUOUS-WAVE IMAGING; CONTRAST AGENT; FLUORESCENCE-ENHANCED OPTICAL IMAGING; MOLECULAR IMAGING; PHOTON MIGRATION;

IMAGE ANALYSIS;

EID: 28944446253     PISSN: 10833668     EISSN: 15602281     Source Type: Journal    
DOI: 10.1117/1.2114748     Document Type: Article

References (49)

1. S. Wang, J. Luo, D. A. Lantrip, D. J. Waters, C. J. Mathias, M. A. Green, P. L. Fuchs, and P. S. Low, "Design and synthesis of (111In) DTPA-folate for use as a tumor-targeted radiopharmaceutical," Bioconjugate Chem. 8, 673-679 (1997). (Pubitemid 27416080)
2. S. S. Gambhir, "Molecular imaging of cancer with positron emission tomography," Nat. Rev. Cancer 2, 683-693 (2002). (Pubitemid 37328919)
3. S. S. Gambhir, E. Bauer, M. E. Black, Q. Liang, M. S. Kokoris, J. R. Barrio, M. Iyer, M. Namavari, M. E. Phelps, and H. R. Herschman, "A mutant herpes simplex virus type 1 thymidine kinase reporter gene shows improved sensitivity for imaging reporter gene expression with positron emission tomography," Proc. Natl. Acad. Sci. U.S.A. 97, 2785-2790 (2000). (Pubitemid 30159249)
4. S. Achilefu, A. Srinivasan, M. A. Schmidt, H. N. Jimenez, J. E. Bugaj, and J. L. Erion, "Novel bioactive and stable neurotensin peptide analogues capable of delivering radiopharmaceuticals and molecular beacons to tumors," J. Med. Chem. 46, 3403-3411 (2003). (Pubitemid 36842424)
5. B. A. Siegel, F. Dehdashti, D. G. Mutch, D. A. Podoloff, R. Wendt, G. P. Sutton, R. W. Burt, P. R. Ellis, C. J. Mathias, M. A. Green, and D. M. Gershenson, "Evaluation of 111In-DTPA-folate as a receptortargeted diagnostic agent for ovarian cancer: initial clinical results," J. Nucl. Med. 44, 700-707 (2003). (Pubitemid 39655203)
6. B. E. Rogers, H. M. Bigott, D. W. McCarthy, D. Della Manna, J. Kim, T. L. Sharp, and M. J. Welch, "MicroPET imaging of a gastrin-releasing peptide receptor-positive tumor in a mouse model of human prostate cancer using a 64Culabeled bombesin analogue," Bioconjugate Chem. 14, 756-763 (2003). (Pubitemid 36875435)
7. L. Aloj, C. Caraco, M. Panico, A. Zannetti, S. Del Vecchio, D. Tesauro, S. De Luca, C. Arra, C. Pedone, G. Morelli, and M. Salvatore, "In vitro and in vivo evaluation of 111In-DTPAGlu-G-CCK8 for cholecystokinin-B receptor imaging," J. Nucl. Med. 45, 485-494 (2004). (Pubitemid 47618625)
8. C. Y. Ke, C. J. Mathias, and M. A. Green, "Folate-receptor-targeted radionuclide imaging agents," Adv. Drug Delivery Rev. 56, 1143-1160 (2004). (Pubitemid 38499700)
9. D. M. Goldenberg, "Perspectives on oncologic imaging with radiolabeled antibodies," Cancer 80, 2431-2435 (1997). (Pubitemid 28009497)
10. C. M. Lahorte, J. L. Vanderheyden, N. Steinmetz, C. Van De Wiele, R. A. Dierckx, and G. Slegers, "Apoptosis-detecting radioligands: current state of the art and future perspectives," Eur. J. Nucl. Med. Mol. Imaging 31, 887-919 (2004). (Pubitemid 38765126)
11. S. Ke, X. Wen, M. Gurfinkel, C. Charnsangavej, Z. Fan, S. Wallace, E. M. Sevick-Muraca, and C. Li, "Near infrared optical imaging of epidermal growth factor receptor in breast cancer xenografts," Cancer Res. 63, 7870-7875 (2003). (Pubitemid 37466721)
12. M. Gurfinkel, A. B. Thompson, W. Ralston, T. L. Troy, A. L. Moore, T. A. Moore, J. D. Gust, D. Tatman, J. S. Reynolds, B. Muggenburg, K. Nikula, R. Pandey, R. H. Mayer, D. J. Hawrysz, and E. M. Sevick- Muraca, "Pharmacokinetics of ICG and HPPH-car for the detection of normal and tumor tissue using fluorescence, near-infrared reflectance imaging: a case study," Photochem. Photobiol. 72, 94-102 (2000).
13. A. Godavarty, M. J. Eppstein, C. Zhang, S. Theru, A. B. Thompson, M. Gurfinkel, and E. M. Sevick-Muraca, "Fluorescence-enhanced optical imaging in large tissue volumes using a gain-modulated ICCD camera," Phys. Med. Biol. 48, 1701-1720 (2003). (Pubitemid 36805845)
14. A. Godavarty, A. B. Thompson, R. Roy, M. Gurfinkel, M. J. Eppstein, C. Zhang, and E. M. Sevick-Muraca, "Diagnostic imaging of breast cancer using fluorescence-enhanced optical tomography: phantom studies," J. Biomed. Opt. 9, 488-496 (2004).
15. R. G. Blasberg, "In vivo molecular-genetic imaging: multi-modality nuclear and optical combinations," Nucl. Med. Biol. 30, 879-888 (2003). (Pubitemid 38040997)
16. J. C. Wu, I. Y. Chen, G. Sundaresan, J. J. Min, A. De, J. H. Qiao, M. C. Fishbein, and S. S. Gambhir, "Molecular imaging of cardiac cell transplantation in living animals using optical bioluminescence and positron emission tomography," Circulation 108, 1302-1305 (2003). (Pubitemid 37174406)
17. P. Ray, A. De, J. J. Min, R. Y. Tsien, and S. S. Gambhir, "Imaging tri-fusion multimodality reporter gene expression in living subjects," Cancer Res. 64, 1323-1330 (2004). (Pubitemid 38235600)
18. A. Jacobs, M. Dubrovin, J. Hewett, M. Sena-Esteves, C. W. Tan, M. Slack, M. Sadelain, X. O. Breakefield, and J. G. Tjuvajev, "Functional coexpression of HSV-1 thymidine kinase and green fluorescent protein: implications for noninvasive imaging of transgene expression," Neoplasia 1, 154-161 (1999).
19. V. Ponomarev, M. Doubrovin, I. Serganova, T. Beresten, J. Vider, A. Shavrin, L. Ageyeva, J. Balatoni, R. Blasberg, and J. G. Tjuvajev, "Cytoplasmically retargeted HSV1-tk/GFP reporter gene mutants for optimization of noninvasive moleculargenetic imaging," Neoplasia 5, 245-254 (2003). (Pubitemid 36763520)
20. A. Zaheer, R. E. Lenkinski, A. Mahmood, A. G. Jones, L. C. Cantley, and J. V. Frangioni, "In vivo near-infrared fluorescence imaging of osteoblastic activity," Nat. Biotechnol. 19, 1148-1154 (2001). (Pubitemid 33115701)
21. W. Wang, S. Ke, Q. Wu, C. Charnsangavej, M. Gurfinkel, J. Gelovani, J. L. Abbruzzese, E. M. Sevick-Muraca, and C. Li, "Nearinfrared optical imaging of integrin alpha v beta 3 in human tumor xenografts," Molecular Imaging 3, 343-351 (2004). (Pubitemid 40245456)
22. A. D. Kim and A. Ishimaru, "Optical diffusion of continuous-wave, pulsed, and density waves in scattering media and comparisons with radiative transfer," Appl. Opt. 37, 5313-5319 (1998). (Pubitemid 128658560)
23. R. Pasqualini, E. Koivunen, and E. Ruoslahti, "A peptide isolated from phage display libraries is a structural and functional mimic of an RGD-binding site on integrins," J. Cell Biol. 130, 1189-1196 (1995).
24. R. Pasqualini, E. Koivunen, and E. Ruoslahti, "Alpha v integrins as receptors for tumor targeting by circulating ligands," Nat. Biotechnol. 15, 542-546 (1997). (Pubitemid 27251571)
25. C. Li, W. Wang, S. Ke, Q. Wu, J. Houston, E. M. Sevick-Muraca, L. Dong, D. Chow, C. Charnsangavej, and J. P. Gelovani, "Dual optical and nuclear imaging of integrin (v)3 in human melanoma xenografts using a single imaging probe," submitted to Eur. J. Nucl. Med. Mol. Imaging.
26. E. Petitclerc, S. Stromblad, T. L. von Schalscha, F. Mitjans, J. Piulats, A. M. Montgomery, D. A. Cheresh, and P. C. Brooks, "Integrin alpha (v)beta3 promotes M21 melanoma growth in human skin by regulating tumor cell survival," Cancer Res. 59, 2724-2730 (1999). (Pubitemid 29269122)
27. D. A. Cheresh and R. C. Spiro, "Biosynthetic and functional properties of an Arg-Gly-Asp-directed receptor involved in human melanoma cell attachment to vitronectin, fibrinogen, and von Willebrand factor," J. Biol. Chem. 262, 17703-17711 (1987). (Pubitemid 18032258)
28. R. Haubner, F. Bruchertseifer, M. Bock, H. Kessler, M. Schwaiger, and H. J. Wester, "Synthesis and biological evaluation of a (99m)Tclabelled cyclic RGD peptide for imaging the alphavbeta3 expression," Nuklearmedizin 43, 26-32 (2004). (Pubitemid 38233141)
29. R. Haubner, H. J. Wester, W. A. Weber, C. Mang, S. I. Ziegler, S. L. Goodman, R. Senekowitsch-Schmidtke, H. Kessler, and M. Schwaiger, "Noninvasive imaging of alpha(v)beta3 integrin expression using 18F-labeled RGD-containing glycopeptide and positron emission tomography," Cancer Res. 61, 1781-1785 (2001). (Pubitemid 32691983)
30. P. C. Brooks, A. M. Montgomery, M. Rosenfeld, R. A. Reisfeld, T. Hu, G. Klier, and D. A. Cheresh, "Integrin alpha v beta 3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels," Cell 79, 1157-1164 (1994).
31. W. T. Philips, "Delivery of gamma-imaging agents by liposomes," Adv. Drug Delivery Rev. 37, 13-32 (1999).
32. H. Palmedo, H. Bender, F. Grunwald, P. Mallmann, P. Zamora, D. Krebs, and H. J. Biersack, "Comparison of fluorine-18 fluorodeoxyglucose positron emission tomography and technetium-99m methoxyisobutylisonitrile scintimammography in the detection of breast tumours," Eur. J. Nucl. Med. 24, 1138-1145 (1997). (Pubitemid 27435021)
33. A. K. Paul, M. Tatsumi, K. Yutani, K. Fujino, K. Hashikawa, and T. Nishimura, "Effects of iterative reconstruction on image contrast and lesion detection in gamma camera coincidence imaging in lung and breast cancers," Nucl. Med. Commun. 23, 103-110 (2002). (Pubitemid 34214313)
34. I. Khalkhali, J. A. Cutrone, I. G. Mena, L. E. Diggles, R. J. Venegas, H. I. Vargas, B. L. Jackson, S. Khalkhali, J. F. Moss, and S. R. Klein, "Scintimammography: the complementary role of Tc-99m sestamibi prone breast imaging for the diagnosis of breast carcinoma," Radiology 196, 421-426 (1995).
35. R. E. Coleman, C. M. Laymon, and T. G. Turkington, "FDG imaging of lung nodules: a phantom study comparing SPECT, camera-based PET, and dedicated PET," Radiology 210, 823-828 (1999). (Pubitemid 29124047)
36. R. Roy, A. B. Thompson, A. Godavarty, and E. M. Sevick-Muraca, "Tomographic fluorescence imaging in tissue phantoms: a novel reconstruction algorithm and imaging geometry," IEEE Trans. Med. Imaging 34, 137-154 (2005).
37. V. Ntziachristos, E. A. Schellenberger, J. Ripoll, D. Yessayan, E. Graves, A. Bogdanov Jr., L. Josephson, and R. Weissleder, "Visualization of antitumor treatment by means of fluorescence molecular tomography with an annexin VCy5.5 conjugate," Proc. Natl. Acad. Sci. U.S.A. 101, 12294-12299 (2004). (Pubitemid 39145437)
38. V. Ntziachristos, C. Bremer, E. Graves, J. Ripoll, and R. Weissleder, "In vivo tomographic imaging of near-infrared fluorescent probes," Molecular Imaging 1, 82-88 (2002).
39. J. C. Rasmussen, A. Joshi, E. M. Sevick-Muraca, J. McGhee, T. Wareing, and G. Failla, "Small animal fluorescence tomography based on the Radiative Transport Equation and time-dependent measurements," Presented at Third Annual Meeting of the Society for Molecular Imaging 4, 374-375 (2005).
40. J. D. Sain and H. H. Barrett, "Performance evaluation of a modular gamma camera using a detectability index," J. Nucl. Med. 44, 58-66 (2003). (Pubitemid 36077713)
41. F. G. Blankenberg and H. W. Strauss, "Nuclear medicine applications in molecular imaging," J. Magn. Reson Imaging 16, 352-361 (2002). (Pubitemid 35167871)
42. M. G. Pomper and D. A. Hammoud, "Positron emission tomography in molecular imaging. Could the promise of personalized patient care be reaching fruition?," IEEE Eng. Med. Biol. Mag. 23, 28-37 (2004).
43. V. Briganti, M. Matteini, P. Ferri, L. Vaggelli, A. Castagnoli, and C. Pieroni, "Octreoscan SPET evaluation in the diagnosis of pancreas neuroendocrine tumors," Cancer Biother. Radiopharm. 16, 515-524 (2001). (Pubitemid 34024439)
44. M. P. Sandler, R. E. Coleman, J. A. Patton, F. J. T. Wackers, and A. Gotschalk, Diagnostic Nuclear Medicine, p. 1272, Lippincott Williams and Wilkins, Philadelphia (2003).
45. M. L. Janssen, W. J. Oyen, I. Dijkgraaf, L. F. Massuger, C. Frielink, D. S. Edwards, M. Rajopadhye, H. Boonstra, F. H. Corstens, and O. C. Boerman, "Tumor targeting with radiolabeled alpha(v)beta(3) integrin binding peptides in a nude mouse model," Cancer Res. 62, 6146-6151 (2002). (Pubitemid 35244464)
46. Z. H. Cho, J. P. Jones, and M. Singh, Foundations of Medical Imaging, Wiley, New York (1993).
47. A. B. Thompson and E. M. Sevick-Muraca, "NIR fluorescence contrast enhanced imaging with ICCD homodyne detection: measurement precision and accuracy," J. Biomed. Opt. 8, 111-120 (2002).
48. J. Houston, A. B. Thompson, M. Gurfinkel, and E. M. Sevick- Muraca, "Sensitivity and depth penetration of continuous wave versus frequency-domain photon migration near-infrared fluorescence contrast-enhanced imaging," Photochem. Photobiol. 77, 420-430 (2003); erratum, 78, 103.
49. A. Godavarty, A. Zhang, M. J. Eppstein, and E. M. Sevick-Muraca, "Fluorescence-enhanced optical imaging of large phantoms using single and simultaneous dual point illumination geometries," Med. Phys. 31, 183-190 (2004). (Pubitemid 38235388)